```html

Xanthopsia (Retinal Disease)

What is Xanthopsia (Retinal Disease)?

Xanthopsia is a type of chromatopsia—a visual disturbance in which colors are perceived incorrectly. People with xanthopsia see the world tinted yellow or amber, even though the surrounding environment is not yellow. Although the term “xanthopsia” describes the symptom, the underlying problem often lies in the retina, the optic nerve, or the visual pathways in the brain. When retinal disease or medication affects the photoreceptor cells (cones) responsible for color vision, the balance of cone activity can shift, creating a persistent yellow hue.

Because color perception is mediated by three types of cones (L‑cones for long‑wavelength light, M‑cones for medium‑wavelength light, and S‑cones for short‑wavelength light), any disruption that preferentially impairs S‑cones or over‑stimulates L‑cones can produce a yellow shift. Xanthopsia is not a disease itself; it is a warning sign that the visual system is being altered.

Common Causes

Several ocular, systemic, and pharmacologic conditions are known to produce xanthopsia. The most frequent causes are:

• Medication toxicity – especially quinine, digoxin, antimalarials (chloroquine, hydroxychloroquine), and some antibiotics (e.g., tetracyclines).
• Retinal detachment or tear – especially when involving the macula, the central retina responsible for detailed vision.
• Age‑related macular degeneration (AMD) – drusen and geographic atrophy can alter cone function.
• Cystoid macular edema – fluid accumulation in the macula changes light scattering.
• Central serous chorioretinopathy (CSCR) – sub‑retinal fluid shifts photoreceptor alignment.
• Retinitis pigmentosa (RP) – progressive loss of photoreceptors, sometimes beginning with color distortion.
• Optic neuritis – inflammation of the optic nerve can impair color transmission.
• Vitamin A deficiency – essential for rod and cone health; deficiency can cause color‑vision abnormalities.
• Liver disease – bilirubin accumulation (jaundice) can lead to a yellowish visual tint.
• Exposure to high‑intensity blue/UV light – can temporarily alter cone sensitivity.

Associated Symptoms

Patients with xanthopsia often notice additional visual or systemic changes. Commonly reported accompanying symptoms include:

• Blurry or hazy vision, especially in the central field.
• Reduced visual acuity (difficulty reading or recognizing faces).
• Difficulty distinguishing between reds and greens (a type of dyschromatopsia).
• Photophobia – increased sensitivity to bright light.
• Floaters or “spots” drifting across the visual field.
• Flashing lights (photopsia) or after‑images.
• Headache or eye‑strain, particularly after prolonged screen use.
• Systemic signs related to the underlying cause, such as fatigue (digoxin toxicity), joint pain (chloroquine), or jaundice (liver disease).

When to See a Doctor

Because xanthopsia can herald serious retinal or systemic disease, prompt evaluation is essential. Seek medical care if you experience any of the following:

• Sudden onset of yellow‑tinted vision, especially if it affects only one eye.
• Rapid deterioration of visual acuity or loss of central vision.
• Accompanying flashes of light, new floaters, or a curtain‑like shadow.
• Persistent headache, nausea, or dizziness with visual changes.
• Recent start or dose change of medications known to affect color vision.
• Signs of liver disease (yellowing of skin or eyes, abdominal pain).
• Any visual change that lasts longer than 24–48 hours.

Diagnosis

Diagnosing the cause of xanthopsia involves a combination of patient history, eye‑exam techniques, and targeted investigations.

1. Detailed History

• Medication review – dose, duration, recent changes.
• Systemic illnesses – liver disease, diabetes, autoimmune disorders.
• Recent travel, infections, or exposures to toxins.

2. Visual Acuity & Refraction

Standard Snellen chart testing determines baseline visual sharpness.

3. Color Vision Testing

• Ishihara plates – to detect red‑green defects.
• Farnsworth‑Munsell 100 Hue test – quantifies subtle hue discrimination, useful for chromatopsia.

4. Fundus Examination

Using ophthalmoscopy or a slit‑lamp with a retinal lens, the clinician looks for:

• Macular edema, drusen, or atrophy.
• Retinal tears, detachments, or hemorrhages.
• Pigmentary changes typical of retinitis pigmentosa.

5. Imaging Studies

• Optical Coherence Tomography (OCT) – high‑resolution cross‑sectional images of retinal layers; detects edema, sub‑retinal fluid, and structural loss.
• Fundus Autofluorescence (FAF) – highlights metabolic changes in the retinal pigment epithelium.
• Fluorescein Angiography (FA) – assesses retinal blood flow and leakage.
• Visual Field Testing – identifies scotomas that may accompany macular disease.

6. Laboratory Tests (when systemic cause suspected)

• Liver function panel – bilirubin, AST, ALT.
• Serum vitamin A level.
• Toxicology screen if drug overdose is possible.

Treatment Options

Treatment is directed at the underlying cause; there is no “pill” that directly reverses a yellow hue.

Medication‑Related Xanthopsia

• Adjust dosage or discontinue the offending drug under physician guidance.
• For digoxin toxicity, digoxin-specific antibody fragments (Digibind) may be administered.
• Replace or supplement with alternative agents when possible (e.g., switch antimalarial regimen).

Retinal Disease Management

• Age‑Related Macular Degeneration – anti‑VEGF intravitreal injections (ranibizumab, aflibercept) for neovascular AMD; AREDS2 vitamins for dry AMD.
• Cystoid Macular Edema – topical/non‑steroidal anti‑inflammatory drugs, oral carbonic anhydrase inhibitors, or intravitreal steroids.
• Central Serous Chorioretinopathy – observation (often resolves spontaneously); for chronic cases, low‑dose oral eplerenone or photodynamic therapy.
• Retinal Detachment – urgent surgical repair (laser photocoagulation, pneumatic retinopexy, scleral buckle, or vitrectomy).
• Retinitis Pigmentosa – currently no cure; low‑vision rehabilitation and potential participation in clinical trials for gene therapy.

Systemic Causes

• Vitamin A deficiency – oral retinol supplementation (usually 10,000 IU daily) under medical supervision.
• Liver disease – treat underlying hepatitis, alcohol‑related injury, or cholestasis; avoid hepatotoxic drugs.

Supportive & Home Measures

• Use high‑contrast, large‑print reading materials.
• Adjust screen color temperature (warm “night” mode) to reduce blue‑light glare.
• Wear UV‑blocking sunglasses outdoors.
• Maintain a balanced diet rich in leafy greens, carrots, and omega‑3 fatty acids to support retinal health.
• Adhere to a regular follow‑up schedule with your ophthalmologist.

Prevention Tips

While not all causes are preventable, many risk factors can be mitigated:

• Medication vigilance – inform every prescriber about any visual changes; never adjust doses on your own.
• Regular eye exams – at least every 1–2 years for adults, more often if you have diabetes, AMD risk factors, or a family history of retinal disease.
• Protect eyes from UV/blue light – wear sunglasses with 100 % UV protection; consider blue‑light filter glasses when using screens for extended periods.
• Control systemic health – maintain healthy blood pressure, blood sugar, and cholesterol to reduce vascular retinal damage.
• Nutrition – diets high in lutein, zeaxanthin (e.g., kale, spinach, corn) support macular pigment density.
• Avoid smoking – tobacco accelerates macular degeneration and impairs vessel health.
• Limit alcohol excess – chronic heavy drinking can lead to liver disease and secondary xanthopsia.

Emergency Warning Signs

If you notice any of the following, seek emergency medical care (e.g., go to an ER or call emergency services):

• Sudden, painless loss of vision in one eye.
• Flashes of light accompanied by a growing shadow or curtain across part of the visual field.
• Severe eye pain with nausea or vomiting.
• Rapidly worsening yellow tint that spreads to both eyes.
• Signs of systemic toxicity (e.g., confusion, irregular heartbeat, severe abdominal pain) while on digoxin, quinine, or similar drugs.

Early detection and treatment dramatically improve outcomes for many of the conditions that cause xanthopsia. If you notice a persistent yellow hue in your vision, schedule an eye examination promptly.

---

References:

• Mayo Clinic. “Color Vision Disorders.” Accessed March 2024.
• Cleveland Clinic. “Age‑Related Macular Degeneration.” 2023.
• National Eye Institute (NEI). “Retinal Detachment.” 2022.
• U.S. Food & Drug Administration. “Digoxin Toxicity: Clinical Management.” 2021.
• World Health Organization. “Guidelines for Vitamin A Supplementation.” 2023.
• American Academy of Ophthalmology. “Clinical Practice Guidelines for Central Serous Chorioretinopathy.” 2022.

```